Table 1.
Vaccine | Birth | 1–2 mo | 4 mo | 6–9 mo | 12–18 mo | 19–23 mo | 4–6 yr | 11–12 yr | |
---|---|---|---|---|---|---|---|---|---|
Hepatitis B | 1st dose | 2nd dose | 3rd dose | ||||||
Rotavirus | 1st dose (2 mo) |
2nd dose | 3rd dose (6 mo)b |
||||||
DTaP | 1st dose (2 mo) |
2nd dose | 3rd dose (6 mo) |
4th dose (15–18 mo) |
5th dose | ||||
Hib | 1st dose (2 mo) |
2nd dose | 3rd dosec
(6 mo) |
3rd or 4th dose (12–15 mo) |
|||||
Pneumococcal conjugate | 1st dose (2 mo) |
2nd dose | 3rd dose (6 mo) |
4th dose (12–15 mo) |
|||||
Inactivated poliovirus | 1st dose (2 mo) |
2nd dose | 3rd dose | 4th dose | |||||
Influenza (IIV) | Annual vaccination 1 or 2 doses (6 mo–18 yr) | ||||||||
MMR | 1st dose (12–15 mo) |
2nd dose | |||||||
Varicella | 1st dose (12–15 mo) |
2nd dose | |||||||
Hepatitis A | 2-dose series | ||||||||
MenACWY-D, MenACWY-CRM or MenACWY-TT | 1st dose and 2nd dose (16 yr) |
||||||||
HPV | 2- or 3-dose series depending on age at initial vaccination |
aDoes not include recommendations for high-risk groups; bFor RotaTeq; cFor ActHIB, Hiberix, or Pentacel.
DTaP, diphtheria tetanus & acellular pertussis (< 7 yrs); Hib, Haemophilus influenzae type b; HPV, human papillomavirus; IIV, inactivated influenza virus; mo, month; MenACWY, meningococcal vaccine ACWY; MMR, measles mumps rubella; yrs, years.